Boston Scientific (BSX) Operating Income Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.37% |
| Dec 31, 2025 | 75.18% |
| Sep 30, 2025 | 48.05% |
| Jun 30, 2025 | 68.38% |
| Mar 31, 2025 | 44.54% |
| Dec 31, 2024 | 26.30% |
| Sep 30, 2024 | 13.86% |
| Jun 30, 2024 | 6.25% |
| Mar 31, 2024 | 4.53% |
| Dec 31, 2023 | 12.86% |
| Sep 30, 2023 | 12.30% |
| Jun 30, 2023 | 5.57% |
| Mar 31, 2023 | 6.28% |
| Dec 31, 2022 | 4.80% |
| Sep 30, 2022 | -1.03% |
| Jun 30, 2022 | 13.46% |
| Mar 31, 2022 | 5.06% |
| Dec 31, 2021 | 5.15% |
| Sep 30, 2021 | 2.15% |
| Jun 30, 2021 | 22.73% |
| Mar 31, 2021 | 4.78% |
| Dec 31, 2020 | 17.30% |
| Sep 30, 2020 | 7.27% |
| Jun 30, 2020 | -18.37% |
| Mar 31, 2020 | 43.49% |
| Dec 31, 2019 | 19.40% |
| Sep 30, 2019 | 43.02% |
| Jun 30, 2019 | 49.89% |
| Mar 31, 2019 | 22.39% |
| Dec 31, 2018 | 20.42% |
| Sep 30, 2018 | 30.38% |
| Jun 30, 2018 | 12.25% |
| Mar 31, 2018 | 26.45% |
| Dec 31, 2017 | 22.14% |
| Sep 30, 2017 | 21.38% |
| Jun 30, 2017 | 15.58% |
| Mar 31, 2017 | 13.18% |
| Dec 31, 2016 | -3.81% |
| Sep 30, 2016 | 14.87% |
| Jun 30, 2016 | -27.80% |
| Mar 31, 2016 | -1.87% |
| Dec 31, 2015 | -21.52% |
| Sep 30, 2015 | -26.12% |
| Jun 30, 2015 | -1.06% |
| Mar 31, 2015 | 15.05% |
| Dec 31, 2014 | 16.76% |
| Sep 30, 2014 | 4.65% |
| Jun 30, 2014 | -17.62% |
| Mar 31, 2014 | 78.08% |